I dont think lawsuits impede selling ore at all-in late

New Post Public Reply Private Reply Replies (1) Message Board
microcaps grajekk #2795

I dont think lawsuits impede selling ore at all-in late summer prices crashed,most articles said steelmakers stopped buying to allow overgrown inventory to subside-which bingo had told us he guessed would happen by October-and prices have been on such a wild ride that likely complicates negotiations- and as bingo said in the following post Chinese are always tough negotiators.
If you are referring to any taint in Chinese eyes Chinese dont usually think that way-remember they invited Nixon to China in grand fashion/grand honor/accolades after Nixons fall-they have a history of people returning to power-and we saw Pres's of Bao Brazil and USA touring another CWRN concession w Bob in July pics. Plus mainland Chinese are so gungho capitalistic now that we forget they are still communist until you read the documents that come out of the central committee etc-a stark reminder-so profit seems to be the primary motive.

I too look forward to the company officially breaking silence-which they say is complicit w counsels advice-though Rocket posted new pics recently.

I am hoping they have been doing the groundwork for uplisting as per May 26 2011 PR, so when the sec matter is settled they will have that ready to go and thus be sec reporting w published financials.

Posted On: 03/28/2012 10:39:04 AM
Avatar
Posted By: Bingo
Re: microcaps #177

That area has been covered back up for now as the light grey magnetite drops off in Fe percentage and will need to be concentrated to give it a huge Fe lift. Magnetite feed-stocks for DRI pellet plants are in short supply and great demand as most of the iron ore sold in the market is Hematite. Magnetite is high in Fe0 and is the desired material used to make DRI (Direct Reduced Iron) pellets. The materials are ground down to mesh sizes in ball mills and then wet magnetically scrubbed 1 to 3 times depending on the total Fe needed; the materials can be up-lifted to the high 60’s, i.e., 66-69% Fe and brings a much greater value than the current market prices for Fines and Lump Raw Crude Iron Ores.. The structure of the Guadalupe iron minerals are disseminated Fe203/Fe304 down to 50 meters at the highest elevation and only 4 meters at the lower elevation where drill-hole 70 was placed. It’s not practical to give out guess-timations of the magnetite deposit; however, it is safe to say that it’s a billion dollar plus reserve, only further wide area and deeper drilling will start to improve the picture. The two new drill-holes are set 105 and 130 meters parallel to 275dg NW at 05dg-NE and should reveal the same materials as DH 69,70 and 71. As an added value the waste materials from this procedure will leave Al203 and Si203, the alumina can further be processed to the higher values and sales for approximately $300.00 per metric ton. Originally Guadalupe was thought to be a nice little mine that could produce maybe a 100 million dollars over a few years, but now that is blown out the window, this puppy is the largest iron mineral deposit known in Baja and maybe even one of the biggest in Mexico., yet to be proven. All this sounds nice, but it will take a very large investment to turn it into a major play, two large steel mills and a couple pellet plant operators are currently in talks with management about investing in the project, and we will see how all this turns out , Bao Steel is coming back tomorrow and they have been very persistent in wanting in… but, as you might guess, the Chinese are never easy to deal with. . LOL

[emphasis added]

Cotton & Western Mining Inc. (CWRN) Stock Research Links

CWRN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Biohaven's BHV-1530 Data Earns a Careful Investor Look

Updated Category News Views 19

Thirty heavily treated cancer patients can make a molecule look brilliant or merely lucky, and BHV-1530 is still living in that uncomfortable early-stage gap. Biohaven presented Phase 1 results at ENA 2026 that deserve real attention, particularly because the responses showed up in patients with few attractive remaining options. But this is not the moment to confuse a...

Continue Reading
Yunnan Tin’s AI Materials Push Has Real Operating Teeth

Updated Category News Views 66

Tin rarely gets the spotlight until the machinery behind modern computing starts demanding more of it. Yunnan Tin Group is making the sensible case that this unglamorous metal can matter a great deal in semiconductors, artificial intelligence infrastructure and new-energy hardware. There is plenty of corporate ambition wrapped around that case, naturally, but a few...

Continue Reading
Yiwu Squishies Turn Viral Demand Into Factory Backlogs Worldwide

Updated Category News Views 21

A pizza-shaped stress toy booking more than one million units is the sort of detail that makes a jaded market watcher sit up before rolling his eyes at the word “viral.” Yiwu’s squishy-toy surge appears to have moved beyond a few social-media impulses and into actual factory scheduling, repeat purchase orders and supermarket procurement. That is meaningful. It is...

Continue Reading
Tongwei's 846 MW Romania Deal Tests Solar Supply Scale

Updated Category News Views 74

Eight hundred forty-six megawatts of panels do not quietly roll out the factory gate. Tongwei’s supply agreement with Rezolv Energy for Romania’s Dama Solar project is a hefty piece of utility-scale solar business, and the first truckload has already left Tongwei’s Nantong facility. That matters more than another polished signing-ceremony photo: equipment is moving,...

Continue Reading
NVE Revenue Pull-Forward Raises Hard Investor Questions

Updated Category News Views 50

A Quarter Can Look Great Until It Doesn’t NVE investors got a nasty lesson in revenue timing, the sort that makes even old hands check the fine print twice. On July 22, 2026, the company reported sequential revenue growth of 43% and net-income growth of 23%. The next trading day, shares vaulted $47.53, or 54%. Then came October, and the floor gave way: NVE reported that...

Continue Reading
Goosehead Restatement Puts Accounting Trust on Trial

Updated Category News Views 87

A filing delay can be irritating; a multi-year no-rely warning is something uglier. Goosehead Insurance told investors on November 9, 2026, that it would not timely file its quarterly report for the period ended September 30 and that prior financial statements must be restated. That is not a garden-variety paperwork hiccup. It reaches back across fiscal 2023, 2024 and...

Continue Reading
Brightstar Picks Warsop for Its Next CEO Chapter Ahead

Updated Category News Views 31

A Handoff With Plenty Riding on the Rails A lottery supplier changing captains is not usually fireworks, but this one deserves a hard look. Brightstar Lottery has named Thomas Warsop to replace Vince Sadusky as chief executive officer and board member effective January 1, 2027. Sadusky is retiring from both posts on that date. The company is telegraphing an orderly baton...

Continue Reading
T. Rowe Price Expands Teams Across 12 Fund Strategies

Updated Category News Views 49

A Quiet Personnel Shift With Real Stakes Twelve strategy changes may sound like administrative wallpaper, but asset managers live and die by who makes the calls. T. Rowe Price is broadening portfolio-management teams across equity and fixed-income offerings while insisting that each strategy's philosophy, process, and risk limits remain intact. Fine. That is the stated...

Continue Reading
Abbe Lane Estate Puts Jewelry Demand on Full Display

Updated Category News Views 101

Glamour Is Walking Back Into the Auction Room Abbe Lane’s jewelry is not being offered as a vague nostalgia exercise; it is arriving with dates, a setting, and a clear split between two December sales. John Moran Auctioneers will lead with The Estate of Abbe Lane on Wednesday, December 9, 2026, at 10:00 a.m. PST, then follow with its Jewelry & Watches auction on...

Continue Reading
First US Extends Buyback Clock Through Year-End 2027

Updated Category News Views 217

A buyback extension is not a thunderclap; it is a bank board keeping a useful tool within reach. First US Bancshares has pushed the expiration of its existing repurchase authorization from December 31, 2026, to December 31, 2027. That matters, but investors ought to resist turning a calendar change into a grand earnings prophecy. The company has bought back 2,122,972...

Continue Reading

Top 5 Most Recently Viewed Articles

commercetools Compilations: Innovations Driving Digital Growth

Updated Category News Views 177

Exciting Launch of commercetools Compilations commercetools has unveiled Compilations, a semi-annual showcase that highlights more than 50 product enhancements, demonstrating the organization’s dedication to innovation and improved customer experiences for users of the commercetools Platform. With over 13,000 deployments and 200 releases, this initiative significantly...

Continue Reading
Join the Class Action Against Red Cat Holdings, Inc. Today

Updated Category News Views 185

Understanding the Class Action Against Red Cat Holdings, Inc. Red Cat Holdings, Inc. is currently under the spotlight due to a class action securities lawsuit filed by the law firm Levi & Korsinsky, LLP. The firm is reaching out to investors who believe they have incurred losses due to the alleged securities fraud that transpired between a specified period. If you have...

Continue Reading
GRAIL Initiates Patient Testing with Innovative Blood Test for Lung Cancer

Updated Category News Views 127

GRAIL Announces Milestone in Lung Cancer Detection GRAIL, Inc. (Nasdaq: GRAL), a pioneering healthcare firm focused on early cancer detection, has achieved a significant milestone by announcing that the first patient has been assessed for eligibility through its innovative non-small cell lung cancer (NSCLC) ctDNA Assay. This groundbreaking development occurs within the...

Continue Reading
Neurocrine Biosciences Enhances Collaboration with Takeda

Updated Category News Views 197

Neurocrine Biosciences Enhances Collaboration with Takeda Neurocrine Biosciences, Inc. (NASDAQ: NBIX) has recently announced an amendment to strengthen the strategic collaboration with Takeda. This partnership focuses on the development and commercialization of osavampator, an innovative therapeutic candidate that holds promise for patients suffering from major depressive...

Continue Reading
LivaNova Prepares to Reveal 2024 Year-End Financials

Updated Category News Views 94

LivaNova's Upcoming Financial Announcement LivaNova PLC (Nasdaq: LIVN), a prominent player in the medical technology sector, is gearing up for an important event. The company will hold a conference call in which they will discuss their financial results from the fourth quarter as well as the entire year of 2024. This event is slated for a Tuesday afternoon and is expected...

Continue Reading